Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Feire Kechuan oral liquid is a traditional Chinese patent medicine formulated for pediatric respiratory conditions. It is composed of eleven herbal ingredients: Ephedra herba (Mahuang), Armeniacae semen amarum (Kuxingren), Gypsum fibrosum (Shigao), Glycyrrhizae radix et rhizoma (Gancao), Lonicerae japonicae flos (Jinyinhua), Forsythiae fructus (Lianqiao), Anemarrhenae rhizoma (Zhimu), Scutellariae radix (Huangqin), Isatidis radix (Banlangen), Ophiopogonis radix (Maidong), and Houttuyniae herba (Yuxingcao). Developed by Heilongjiang Kuihua Pharmaceutical, it is primarily indicated for clearing heat, detoxifying, dispersing the lungs, and resolving phlegm in children suffering from fever, cough, sputum, and asthma caused by wind-heat invading the lungs. It is currently being evaluated in clinical trials for pediatric acute bronchitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoer Feire Kechuan oral liquid.